Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
Bioavailability |
49.0 |
% |
49 |
% |
PO, oral; |
DRUGBANK |
T Max |
0.75 |
h |
0.5-1 |
h |
PO, oral; |
DRUGBANK |
Clearance |
7.2 |
L/h |
7.2 |
L/h |
|
DRUGBANK |
Clearance |
0.10 |
L/h/kg |
1.71 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
92.0 |
L |
92.0 |
L |
|
DRUGBANK |
Volume of Distribution |
1.3 |
L/kg |
1.31 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
18.5 |
h |
15-22 |
h |
|
DRUGBANK |
Half-life |
18.5 |
h |
15-22 |
h |
Active metabolite; |
DRUGBANK |
Half-life |
18.0 |
h |
18 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Eliminate Route |
60.0 |
% |
~60 |
% |
Urinary excretion; |
DRUGBANK |
Eliminate Route |
30.0 |
% |
~30 |
% |
Faeces excretion; |
DRUGBANK |
Protein Binding |
99.0 |
% |
>99 |
% |
plasma proteins; |
DRUGBANK |